Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-03

FDA Approved: DECITABINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for decitabine submitted by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

SUPPL AP for DECITABINE (DECITABINE)